Hypofractionated radiotherapy for early glottic cancer: a retrospective interim analysis of a single institution
Jeong Won Lee, Jeong Eun Lee, Junhee Park, Jin Ho Sohn, Dongbin Ahn
Radiat Oncol J. 2019;37(2):82-90.   Published online 2019 Jun 30     DOI: https://doi.org/10.3857/roj.2019.00143
Citations to this article as recorded by Crossref logo
Hypofractionated (2.75 Gy per fraction) versus Conventionally Fractionated Primary Radiotherapy for T2N0M0 Carcinoma of the Glottis
Josef Kovarik, Charles Kelly, Michelle Cunnell, Fatima Jamil, Muhammad Shahid Iqbal
International Archives of Otorhinolaryngology.2023; 27(01): e16.     CrossRef
Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
Tae Hoon Lee, Joo Ho Lee, Seong Keun Kwon, Eun-Jae Chung, Hong-Gyun Wu
Radiation Oncology Journal.2022; 40(2): 120.     CrossRef
Radiothérapie du carcinome épidermoïde du larynx de stade précoce, étage glottique : intérêt de l’hypofractionnement ?
M. Tonneau, R. Matta, S. Lals, X. Mirabel, F. Crop, T. Lacornerie, D. Pasquier, A. Escande, X. Liem
Cancer/Radiothérapie.2021; 25(8): 801.     CrossRef
Prediction of VMAT delivery accuracy with textural features calculated from fluence maps
Jong Min Park, Jung-in Kim, So-Yeon Park
Radiation Oncology.2019;[Epub]     CrossRef